Diabetes and schizophrenia 2005: are we any closer to understanding the link? (Q36310303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Diabetes and schizophrenia 2005: are we any closer to understanding the link? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Leslie Citrome

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Chris Bushe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

6 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

56-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

Consensus development conference on antipsychotic drugs and obesity and diabetes

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Quetiapine in the successful treatment of psychosis and comorbid brittle diabetes mellitus: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Relationship of atypical antipsychotics with development of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Metabolic issues in patients with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Prevalence and correlates of diabetes in national schizophrenia samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Effects of quetiapine and haloperidol on body mass index and glycaemic control: a long-term, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Schizophrenia, the metabolic syndrome and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Diabetes in a high secure hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Diabetes mellitus in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Focus on the clinical ramifications of antipsychotic choice for the risk for developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

Antipsychotic Drugs May Worsen Metabolic Control in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058379

21 January 2018

Identifiers

DOI

10.1177/0269881105058379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16280338%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference